Skip to content

Direct Oral Anticoagulants and Management of Blleding Following Dental Extractions. A Prospective Cohort Study.

Direct Oral Anticoagulants and Management of Blleding Following Dental Extractions. A Prospective Cohort Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06365242
Acronym
DOACS_1
Enrollment
49
Registered
2024-04-15
Start date
2020-07-23
Completion date
2022-12-23
Last updated
2024-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Hemorrhage

Keywords

Direct Oral Anticoagulants, oral Surgical Procedure, Post-operative complications

Brief summary

Evaluation of DOACs treatment on post-extraction bleeding

Detailed description

Consecutive patients requiring at least one dental extraction were enrolled. DOACs regimen was either maintained or suspended. Patients were classified in subgroups depending on the number of teeth extracted per procedure (≤ 3 or \> 3), the need for flap raising and the performance of osteotomy. Bleeding was recorded intraoperatively, perioperatively at 20, 40, 60 and 80 minutes after the procedure, and in the first seven days post-operatively.

Interventions

None listed

Sponsors

University of Pisa
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \>18 years * patients under pharmacological treatment with DOACs * patients requiring at least one dental extraction * patients willing to take part in the study and to sign informed consent

Exclusion criteria

* patients below 18 years of age * patients treated with antiplatelet therapy or vitamin K antagonists * patients presenting with an International Normalized Ratio (INR) \>3.0 * patients suffering from congenital or acquired coagulopathies (e.g. haemophilia, coagulation factors deficiency, von Willebrand disease, thrombocytopenia, cirrhosis)

Design outcomes

Primary

MeasureTime frameDescription
Peri-operative hemorrhage20 minutes to 80 minutesEvaluation of early post-operative hemorrhage classified as absent, mild, oozing, moderate, and severe.
Post-operative bleedingday 1 to 7 post-operativelyEvaluation of post-operative bleeding classified as absent, mild, oozing, moderate, and severe.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026